We can't eliminate epidemics, but we can minimize their impact.
Political instability, proliferation of global transportation, population expansion, increasing demand for proteins and ecological change are all contributing to increased infectious disease risk. That's why we partner with businesses and governments worldwide to identify and track pathogens from their source, then contextualize the risk based on socioeconomic, political, environmental and other factors.
Our analytics enable innovative insurance products.
Years of deep scientific leadership and portfolio-specific asset analysis are our foundation for creating sustainable business tools for a volatile world. By understanding marketplace mechanisms and our partners' needs, we help identify risk transfer and intervention opportunities that would otherwise remain hidden.
Insights must be actionable, global and dynamic.
We can confront infectious disease risk for a simple reason — we have best-in-class models informed by the most comprehensive epidemiological database ever created. Our platform processes hundreds of data sources covering historical pandemics to emerging outbreaks.
We strive to make the world more resilient to epidemics.
We believe that working with the insurance industry and governmental organizations on improved techonologies is one of the best ways to help mitigate the impact of infectious diseases.
Metabiota's offering enables reinsurers and insurers to accurately quantify complex infectious disease risk. Whether it's to create novel insurance products or improve capital utilization and enterprise risk management, Metabiota partners with customers to improve insurability through better understanding and analysis of underlying exposure.
Government agencies responsible for outbreak response planning and implementation leverage Metabiota's platform to assess preparedness and conduct what-if analyses to ensure readiness for events of varying impact.